Chlorophyll

The deodorising effect has some historical support. Anticancer claims rely on preclinical data. Mostly a low-risk, low-reward supplement.

A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.

Chlorophyllin can bind certain carcinogens (aflatoxin) in the GI tract—one Chinese RCT showed reduced aflatoxin biomarkers. Deodorising use dates to the 1950s with mixed study quality. Topical wound-healing data are old.

• May bind dietary carcinogens in the GI tract
• Historical deodorising properties
• Low risk at standard doses

100–300 mg/day of chlorophyllin. Liquid forms often use 1–2 tablespoons.

• Green stool and urine
• Mild GI upset
• Possible copper accumulation at very high doses

Turns stool green (harmless). Chlorophyllin is copper-containing—excessive doses theoretically contribute to copper load.

Supplemental chlorophyllin is structurally different from natural chlorophyll. Many health claims are extrapolated from weak data.

• Longevity18